Healthy for Two-Home Visiting (H42-HV): Health Coaching for Pregnant Women
Launched by JOHNS HOPKINS UNIVERSITY · Nov 9, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
The Healthy for Two-Home Visiting (H42-HV) trial is studying a special health coaching program designed for pregnant and postpartum women, particularly those who are Black or Latinx. The goal is to see if this tailored program can help women keep their weight in check after giving birth, compared to regular home visiting services. This is important because many women struggle with weight after pregnancy, and the study aims to improve health outcomes for those who may face more challenges.
To be eligible for this study, participants need to be pregnant, no more than 33 weeks along, and have a body mass index (BMI) of 25 or higher before pregnancy. They must also be able to speak English or Spanish and be enrolled in a home visiting program. If you join the study, you can expect to receive personalized coaching and support in your home, along with help in tracking your weight after giving birth. It's important to note that certain health conditions, like diabetes or recent hospitalizations for mental health issues, may prevent someone from participating. Overall, this study aims to provide support that meets the unique needs of pregnant and postpartum women to promote better health for them and their babies.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant, ≤33 weeks gestation
- • Singleton pregnancy
- • Pre pregnancy BMI≥25.0 Kg/m\^2 (calculated based on self-reported pre pregnancy height and weight)
- • Able to provide informed consent
- • English or Spanish speaking
- • Completion of screening and baseline data collection
- • Willing to participate in the intervention and data collection procedure (e.g., home weights)
- Exclusion Criteria:
- • Type 1 diabetes or taking insulin prior to delivery
- • Pregnant with multiple fetuses
- • Unable to walk 1 block without pain or shortness of breath
- • Not cleared by the study's clinicians or home visiting program staff
- • Planning to relocate from area during next 1 year
- • Active substance abuse disorder (except marijuana)
- • Psychiatric or substance use related hospitalization in past 1 year
- • Active eating disorder
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Kelly Bower, PhD, MSN/MPH
Principal Investigator
Johns Hopkins School of Nursing
Wendy Bennett, MD,MPH
Principal Investigator
Johns Hopkins School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials